Pharmacological Histone Deacetylation Distinguishes Transcriptional Regulators

E-ISSN： 1873-4294|17|14|1611-1622

ISSN： 1568-0266

Source： Current Topics in Medicinal Chemistry, Vol.17, Iss.14, 2017-04, pp. : 1611-1622

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Histone Deacetylation and Motor Neuron Degeneration

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 9, Iss. 3, 2010-07 ,pp. : 279-284

Bentham Science Publishers

Access to resources Recommend Favorite

Histone Deacetylation: An Attractive Target for Cancer Therapy?

By Al-Janadi Anas Chandana Sreenivasa R. Conley Barbara A.

Drugs in R&D, Vol. 9, Iss. 6, 2008-01 ,pp. : 369-383

Adis International

Access to resources Recommend Favorite

Epigenetically Active Drugs Inhibiting DNA Methylation and Histone Deacetylation

Current Pharmaceutical Design, Vol. 23, Iss. 8, 2017-04 ,pp. : 1167-1174

Bentham Science Publishers

Access to resources Recommend Favorite

Pharmacological Regulators of Intracellular Calcium Release Channels

Current Pharmaceutical Design, Vol. 13, Iss. 24, 2007-08 ,pp. : 2428-2442

Bentham Science Publishers

Access to resources Recommend Favorite

Pharmacological Inhibition of the Bcl-2 Family of Apoptosis Regulators as Cancer Therapy

Current Molecular Pharmacology, Vol. 1, Iss. 3, 2008-11 ,pp. : 244-254

Bentham Science Publishers

Access to resources Recommend Favorite